Arisaph Pharmaceuticals
Boston
About Arisaph Pharmaceuticals
Arisaph Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing therapies for cancer, cardiovascular disease, and diabetes. Its products include dipeptidylpeptidase IV inhibitors, stable GLP-1 agonists, HDL modulators and plaque reducers, and tumor activated pro-soft drugs. The company was founded in 1999 and is based in Boston, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.0M
- Last round: Series Unknown (Nov 2013)
- Website: arisaph.com
- Phone: 6172923309
Industries & Categories
Biotechnology, Diabetes, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/arisaph-pharmaceuticals-3273055 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.